Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$4.09 - $6.5 $105,931 - $168,350
25,900 New
25,900 $31,000
Q3 2021

Nov 10, 2021

SELL
$9.7 - $14.34 $106,699 - $157,740
-11,000 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$13.43 - $19.16 $147,730 - $210,760
11,000 New
11,000 $19,000
Q2 2020

Aug 10, 2020

SELL
$4.67 - $8.95 $49,969 - $95,764
-10,700 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$3.95 - $7.4 $42,265 - $79,180
10,700 New
10,700 $7,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $673M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.